Clinical Trial Update: Use of Epoetin Alfa and Iron Derisomaltose in Treatment of Anemia in Patients With Sepsis or Septic Shock: a Randomized Controlled Trial [Phase 4]

View source ↗

Summary

Phase 4 randomized controlled trial evaluating epoetin alfa with iron isomaltose for treating anemia in patients with sepsis or septic shock. The study is curre…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Sepsis
• Septic Shock

Drugs mentioned

• EPOETIN ALFA (EPOETIN ALFA)
• Iron isomaltose (iron isomaltose)

Snippet

Sponsor: Piotr Czempik | Conditions: Anemia, Sepsis | Phase 4 | Status: RECRUITING